COVID-19 Has Revealed Fatal Flaws in the U.S. Drug Supply Chain June 12, 2020 Anthony Loiacono, SCB Contributor The U.S. is seeing dangerous effects from an over-reliance on offshore manufacturers.Read More
Podcast | How Healthcare Giant Johnson & Johnson Is Making Its Supply Chain SustainableRegulation & Compliance
DP World Says Curb on Red Sea Attacks Could Bring Ocean Freight Rates ‘Crashing Down’ Global Gateways
Embattled Drayage Providers Struggle to Survive as They Await Recovery in the MarketLast Mile Delivery